Mauritius vs Sao Tome and Principe: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Mauritius
0.8%
in 2024
Sao Tome and Principe
0.8%
in 2024
Mauritius rank
44th
Sao Tome and Principe rank
44th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Mauritius
- Sao Tome and Principe
How they compare
Mauritius currently reports 0.8% against 0.8% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Mauritius ahead.
Mauritius ranks 44th and Sao Tome and Principe ranks 44th of 246 countries.
Mauritius has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritius | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.2% | 0.9% | 0.3% | Mauritius |
| 2020s | 0.8% | 0.8% | 0.0% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Mauritius or Sao Tome and Principe?
- Mauritius, at 0.8% against 0.8% in Sao Tome and Principe as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Mauritius and Sao Tome and Principe?
- 0.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Sao Tome and Principe?
- 10 years are reported by both, from 2015 to 2024.
- How do Mauritius and Sao Tome and Principe rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Mauritius ranks 44th and Sao Tome and Principe ranks 44th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.